Sourcing Amikacin Impurity 11?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(2S)-4-Amino-N-{(1R,2S,5S)-5-amino-4-[(6-amino-6-deoxy-alpha-D-glycero-hexopyranosyl)oxy]-2-[(3-{[(2S)-4-amino-2-hydroxybutanoyl]amino}-3-deoxy-alpha-D-threo-hexopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide
pharmaceutical raw material
(3S,4R,6S)-4,6-Diamino-3-[(3-{[(2S)-4-amino-2-hydroxybutanoyl]amino}-3-deoxy-alpha-D-threo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 6-amino-6-deoxy-alpha-D-glycero-hexopyranoside
pharmaceutical raw material
Sourcing Amikacin Impurity 11?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Amikacin Impurity 11 is a stereochemically defined pharmaceutical intermediate used as a reference standard for quality control in amikacin manufacturing. This compound is a highly polar, non-aromatic molecule containing multiple alcohol, amine, and ether functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
(2S)-4-amino-N-[(1R,2S,3R,4R,5S)-5-amino-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-2,3-dihydroxycyclohexyl]-2-hydroxybutanamide
WAYVGMHNBXWDCP-USYQMBJISA-N
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)N